BACKGROUND: Understanding racial influences on human papillomavirus (HPV) distribution in women with atypical squamous cells of undetermined significance (ASCUS) cytology via partial genotyping in a statewide population can inform HPV-based prevention efforts. METHODS: Women aged 21 to 65 years with any cytology result and partial HPV genotyping for ASCUS triage between January 1, 2014, and December 31, 2017, were included. All women attended a Mississippi State Department of Health clinic. Age, race, cytopathologic, and HPV data were extracted from the electronic health record and analyzed. Cytologic specimens were processed with ThinPrep and HPV testing with the Cobas 4800 assay. HPV genotypes were evaluated in hierarchical categories. Chi-square tests and multinomial logistic regression models evaluated associations between race and type prevalence. RESULTS: There were 43,106 women who underwent cervical cancer screening with cytology and ASCUS triage. Of these, 34,363 (80.2%) had normal cytology, 4672 (10.9%) had ASCUS, 2683 (6.3%) had a low-grade squamous intraepithelial lesion, and 633 (1.5%) had a high-grade squamous intraepithelial lesion. Blacks represented 69.3% of the sample and had a higher proportion of HPV-positive ASCUS (6.5%) in comparison with whites (5.6%). Blacks had significantly decreased odds of HPV-16 (odds ratio [OR], 0.66; 95% confidence interval [CI], 0.6-0.9; P = .002) and significantly increased odds for 12 other types (OR, 1.37; 95% CI, 1.2-1.5; P < .0001) in comparison with whites. CONCLUSIONS: In a diverse population, significant differences in HPV genotypes are shown by race. Importantly, blacks with ASCUS are less likely to be positive for HPV-16 in comparison with whites. Ongoing work is evaluating the individual genotype prevalence and genotype-specific risk of precancer by race.
BACKGROUND: Understanding racial influences on human papillomavirus (HPV) distribution in women with atypical squamous cells of undetermined significance (ASCUS) cytology via partial genotyping in a statewide population can inform HPV-based prevention efforts. METHODS:Women aged 21 to 65 years with any cytology result and partial HPV genotyping for ASCUS triage between January 1, 2014, and December 31, 2017, were included. All women attended a Mississippi State Department of Health clinic. Age, race, cytopathologic, and HPV data were extracted from the electronic health record and analyzed. Cytologic specimens were processed with ThinPrep and HPV testing with the Cobas 4800 assay. HPV genotypes were evaluated in hierarchical categories. Chi-square tests and multinomial logistic regression models evaluated associations between race and type prevalence. RESULTS: There were 43,106 women who underwent cervical cancer screening with cytology and ASCUS triage. Of these, 34,363 (80.2%) had normal cytology, 4672 (10.9%) had ASCUS, 2683 (6.3%) had a low-grade squamous intraepithelial lesion, and 633 (1.5%) had a high-grade squamous intraepithelial lesion. Blacks represented 69.3% of the sample and had a higher proportion of HPV-positive ASCUS (6.5%) in comparison with whites (5.6%). Blacks had significantly decreased odds of HPV-16 (odds ratio [OR], 0.66; 95% confidence interval [CI], 0.6-0.9; P = .002) and significantly increased odds for 12 other types (OR, 1.37; 95% CI, 1.2-1.5; P < .0001) in comparison with whites. CONCLUSIONS: In a diverse population, significant differences in HPV genotypes are shown by race. Importantly, blacks with ASCUS are less likely to be positive for HPV-16 in comparison with whites. Ongoing work is evaluating the individual genotype prevalence and genotype-specific risk of precancer by race.
Keywords:
atypical squamous cells of undetermined significance; cervical cancer; cervical cancer screening; human papillomavirus (HPV); human papillomavirus genotypes
Authors: Julia C Gage; William C Hunt; Mark Schiffman; Hormuzd A Katki; Li A Cheung; Orrin Myers; Jack Cuzick; Nicolas Wentzensen; Walter Kinney; Philip E Castle; Cosette M Wheeler Journal: Obstet Gynecol Date: 2016-12 Impact factor: 7.661
Authors: Long Fu Xi; Nancy B Kiviat; Allan Hildesheim; Denise A Galloway; Cosette M Wheeler; Jesse Ho; Laura A Koutsky Journal: J Natl Cancer Inst Date: 2006-08-02 Impact factor: 13.506
Authors: Mark Schiffman; Sean Boyle; Tina Raine-Bennett; Hormuzd A Katki; Julia C Gage; Nicolas Wentzensen; Janet R Kornegay; Raymond Apple; Carrie Aldrich; Henry A Erlich; Thanh Tam; Brian Befano; Robert D Burk; Philip E Castle Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-06-18 Impact factor: 4.254
Authors: Peng Guan; Rebecca Howell-Jones; Ni Li; Laia Bruni; Silvia de Sanjosé; Silvia Franceschi; Gary M Clifford Journal: Int J Cancer Date: 2012-03-20 Impact factor: 7.396
Authors: Mark Schiffman; Noorie Hyun; Tina R Raine-Bennett; Hormuzd Katki; Barbara Fetterman; Julia C Gage; Li C Cheung; Brian Befano; Nancy Poitras; Thomas Lorey; Philip E Castle; Nicolas Wentzensen Journal: Int J Cancer Date: 2016-08-26 Impact factor: 7.396
Authors: Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi Journal: Nat Rev Dis Primers Date: 2016-12-01 Impact factor: 52.329
Authors: Susan Hariri; Martin Steinau; Allen Rinas; Julia W Gargano; Christina Ludema; Elizabeth R Unger; Alicia L Carter; Kathy L Grant; Melanie Bamberg; James E McDermott; Lauri E Markowitz; Noel T Brewer; Jennifer S Smith Journal: PLoS One Date: 2012-03-29 Impact factor: 3.240
Authors: Thomas C Wright; Mark H Stoler; Valentin Parvu; Karen Yanson; Karen Eckert; Salma Kodsi; Charles K Cooper Journal: Am J Clin Pathol Date: 2019-01-01 Impact factor: 2.493
Authors: Jacqueline Mix; Mona Saraiya; Benjamin D Hallowell; Brian Befano; Li C Cheung; Elizabeth R Unger; Julia W Gargano; Lauri E Markowitz; Philip E Castle; Tina Raine-Bennett; Joan Walker; Rosemary Zuna; Mark Schiffman; Nicolas Wentzensen; Julia C Gage Journal: J Natl Cancer Inst Date: 2022-06-13 Impact factor: 11.816
Authors: Carolann Risley; Mary W Stewart; Kim R Geisinger; Laree M Hiser; Jody C Morgan; Kenyata J Owens; Krishna Ayyalasomayajula; Rhonda M Rives; Ashish Jannela; Dianne E Grunes; Lei Zhang; Mark Schiffman; Nicolas Wentzensen; Megan A Clarke Journal: Prev Med Date: 2021-07-20 Impact factor: 4.018